Quality Systems, Inc. : to Present at 11th Annual JMP Securities Research Conference
05/08/2012| 05:05am US/Eastern
Recommend:
Quality Systems, Inc. (NASDAQ: QSII) announced today that its management
plans to present its corporate story at the 11th Annual JMP
Securities Research Conference.
The conference, which will showcase more than 250 publicly traded and
privately held companies across the technology, healthcare, financial
services, real estate and consumer sectors for institutional investors,
is scheduled for Monday, May 14, 2102 through Wednesday, May 16, 2012,
at The Ritz-Carlton, San Francisco.
Quality Systems' Chief Financial Officer Paul A. Holt is scheduled to
present on Monday, May 14, 2012, at 11:00 A.M. local time. The
presentation will address the company's operations and strategy. Each
participating company is scheduled for a 25-minute presentation,
followed by a 25-minute breakout question-and-answer session.
A webcast of Quality Systems' audio presentation will be available on
Monday, May 14, 2011 (beginning at the start time of the presentation)
and can be viewed by accessing http://wsw.com/webcast/jmp17/qsii/.
It will be archived for 90 days.
San Francisco-based JMP Securities is a full-service investment bank
that provides equity research, institutional brokerage and investment
banking services to public and private growth companies and their
investors. The firm is a subsidiary of publicly traded JMP Group Inc.
(NYSE:JMP). For more information, go to www.jmpsecurities.com.
About Quality Systems, Inc.
Irvine, Calif.-based Quality
Systems, Inc. and its NextGen Healthcare subsidiary develop and
market computer-based practice management, electronic health records and
revenue cycle management applications as well as connectivity products
and services for medical and dental group practices and small hospitals.
Visit www.qsii.com
and www.nextgen.com
for additional information.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the
meaning of the federal securities laws. Statements regarding future
events, developments, the Company's future performance, as well as
management's expectations, beliefs, intentions, plans, estimates or
projections relating to the future (including, without limitation,
statements concerning revenue and net income), are forward-looking
statements within the meaning of these laws and involve a number of
risks and uncertainties. Management believes that these forward
looking statements are reasonable and are based on reasonable
assumptions and forecasts, however, undue reliance should not be placed
on such statements that speak only as of the date hereof. Moreover,
these forward-looking statements are subject to a number of risks and
uncertainties, some of which are outlined below. As a result, actual
results may vary materially from those anticipated by the
forward-looking statements. Among the important factors that could cause
actual results to differ materially from those indicated by such
forward-looking statements are: the volume and timing of systems sales
and installations; length of sales cycles and the installation process;
the possibility that products will not achieve or sustain market
acceptance; seasonal patterns of sales and customer buying behavior;
impact of incentive payments under The American Recovery and
Reinvestment Act on sales and the ability of the Company to meet
continued certification requirements; the development by competitors of
new or superior technologies; the timing, cost and success or failure of
new product and service introductions, development and product upgrade
releases; undetected errors or bugs in software; product liability;
changing economic, political or regulatory influences in the health-care
industry; changes in product-pricing policies; availability of
third-party products and components; competitive pressures including
product offerings, pricing and promotional activities; the Company's
ability or inability to attract and retain qualified personnel; possible
regulation of the Company's software by the U.S. Food and Drug
Administration; uncertainties concerning threatened, pending and new
litigation against the Company including related professional services
fees; uncertainties concerning the amount and timing of professional
fees incurred by the Company generally; changes of accounting estimates
and assumptions used to prepare the prior periods' financial statements;
general economic conditions; and the risk factors detailed from time to
time in the Company's periodic reports and registration statements filed
with the Securities and Exchange Commission. A significant portion of
the Company's quarterly sales of software product licenses and computer
hardware is concluded in the last month of the fiscal quarter, generally
with a concentration of such revenues earned in the final ten business
days of that month. Due to these and other factors, the Company's
revenues and operating results are very difficult to forecast. A major
portion of the Company's costs and expenses, such as personnel and
facilities, are of a fixed nature and, accordingly, a shortfall or
decline in quarterly and/or annual revenues typically results in lower
profitability or losses. As a result, comparison of the Company's
period-to-period financial performance is not necessarily meaningful and
should not be relied upon as an indicator of future performance. The
Company undertakes no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events or
otherwise.
Quality Systems, Inc.
Susan J. Lewis, 303-804-0494
slewis@qsii.com
© Business Wire 2012
Recommend :
